Gadobenate dimeglumine

Generic name: Gadobenate Dimeglumine
Brand names: Multihance
Dosage form: intravenous solution (529 mg/mL)
Drug class: Magnetic resonance imaging contrast media

Usage of Gadobenate dimeglumine

Gadobenate dimeglumine is a contrast agent that has magnetic properties. It is used in combination with magnetic resonance imaging (MRI) or magnetic resonance angiography (MRA) to allow blood vessels, organs, and other non-bony tissues to be seen more clearly on the MRI or MRA.

Gadobenate dimeglumine is used to help diagnose certain disorders of the brain and spine (central nervous system). This medication is also used to diagnose atherosclerosis (clogged arteries).

Gadobenate dimeglumine may also be used for purposes not listed in this medication guide.

Gadobenate dimeglumine side effects

Get emergency medical help if you have signs of an allergic Reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some side effects of gadobenate dimeglumine may occur up to several days after injection.

Gadobenate dimeglumine can cause a life-threatening condition in people with advanced kidney disease. Call your doctor right away if you have any symptoms of this condition, such as:

burning, itching, swelling, scaling, and tightening or hardening of your skin;

muscle weakness;

joint stiffness in your arms, hands, legs, or feet;

deep bone pain in your ribs or your hips;

trouble moving; or

skin redness or discoloration.

Also call your doctor at once if you have:

kidney problems--little or no urinating; painful or difficult urination; swelling in your feet or ankles; feeling tired or short of breath;

a seizure (convulsions);

pounding heartbeats or fluttering in your chest;

breathing problems; or

pain, burning, swelling, blistering, or skin changes where the injection was given.

Common side effects of gadobenate dimeglumine may include:

headache;

nausea; or

unusual or unpleasant taste in your mouth.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Gadobenate dimeglumine

Gadobenate dimeglumine can cause a life-threatening condition in people with advanced kidney disease. You should not receive this medication if you have kidney disease or if you are on dialysis.

Gadobenate dimeglumine can stay in your body for months or years after you receive gadobenate dimeglumine. It is not known whether this could cause any health problems in people whose kidneys work properly. Tell your doctor if you have HAD repeated scans with a contrast agent, and provide the date of your last scan.

You should not receive gadobenate dimeglumine if you are allergic to it.

Tell your doctor if you have ever had:

kidney disease;

any type of reaction to a contrast agent;

diabetes;

high blood pressure;

liver disease;

asthma, hay fever, food or drug allergies;

an injury, surgery, or severe infection; or

if you are over 60 years old.

It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant.

It may not be safe to breast-feed while using this medicine. Ask your doctor about any risk.

Relate drugs

How to use Gadobenate dimeglumine

Usual Adult Dose for CNS Magnetic Resonance Imaging:

0.1 mmol/kg (0.2 mL/kg) as a rapid bolus intravenous injection. To ensure complete injection of the medium, the injection should be followed by a saline flush of at least 5 mL.

Usual Adult Dose for Magnetic Resonance Angiography:

MRA of renal and aorto-ilio-femoral vessels: 0.1 mmol/kg (0.2 mL/kg) as a rapid bolus intravenous injection followed by a saline flush of at least 20 mL either manually or using an automatic injector system.Imaging may be started immediately after the administration of gadobenate meglumine, with scan delay calculated by test bolus or automatic bolus detection technique. If bolus timing is not determined by an automatic contrast detection pulse sequence, then a test bolus injection of 1-2 ml of gadobenate meglumine should be used to calculate the scan delay.

Usual Pediatric Dose for CNS Magnetic Resonance Imaging:

2 years and older:0.1 mmol/kg (0.2 mL/kg) as a rapid bolus intravenous injection. To ensure complete injection of the medium, the injection should be followed by a saline flush of at least 5 mL.

Warnings

Gadobenate dimeglumine can cause a life-threatening condition in people with advanced kidney disease. You should not receive this medication if you have kidney disease or if you are on dialysis.

What other drugs will affect Gadobenate dimeglumine

Tell your doctor about all medicines you have recently used, especially cancer medicines, such as:

cisplatin;

Daunorubicin, doxorubicin;

etoposide;

methotrexate;

Paclitaxel;

Tamoxifen; or

vinblastine, vincristine.

This list is not complete. Other drugs may interact with gadobenate dimeglumine, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.